comprehensive -WSS

comprehensive

author：fashion 2025-10-03 00:40:10 - browse：38256

An advisory committee to the Food and Drug Administration will convene on Tuesday to evaluate the benefits of renal denervation, a one-time surgical procedure that works to reduce blood pressure. The promise — and the potential market — is enormous, but the data on how well the procedure works remains contentious.

The committee will evaluate data from two companies vying for market approval: ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and device giant Medtronic, both of which have made surgical systems to treat hypertension.

Data from an analysis of three randomized clinical trials of ReCor Medical’s device showed a modest decrease in blood pressure after two months compared to a control group that received a placebo procedure. Medtronic’s late-stage trial showed that renal denervation reduced hypertension when measuring blood pressure in the doctor’s office, but did not show a reduction in blood pressure when patients measured it at home over 24 hours. At-home blood pressure is considered the more accurate measure, as blood pressure levels tend to artificially rise with anxiety in the clinic. Neither study presented serious safety concerns.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Ukraine taking heavy casualties 10 weeks into its counteroffensive

Wikipedia

WSS

FDA panel issues narrow recommendation for Covid vaccine booster doses

Methadone doses haven’t kept up in the age of fentanyl

FDA approves first treatment for ultra

Naloxone nonprofit donates 200,000 doses after FDA approval

Hilary expected to bring catastrophic, life

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

entertainment

comprehensive

leisure time

The high cost of giving birth even with insurance

Wegovy’s successful heart trial raises vital question about weight loss

Trump demands the U.S. pay no more for drugs than other countries … again

Trump's false claims about Georgia's 2020 election long debunked

As demand for Covid shots wanes, Moderna seeks its next success

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Activists slam private health insurers over coverage restrictions

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

In same hospitals, Black patients receive fewer opioids than white patients

focus

For Cytokinetics, FDA rejection of heart drug would help, not hinder

As Maui death toll rises, number of missing remains unclear

Living with Hashimoto's and celiac disease, and med school, too

For Cytokinetics, FDA rejection of heart drug would help, not hinder

In same hospitals, Black patients receive fewer opioids than white patients

Maui's cultural, historic landmarks damaged in the devastating wildfires

Wikipedia

Wikipedia

explore

explore